89bio
ETNB
ETNB was delisted on the 29th of October, 2025.
0 hedge funds and large institutions have $0 invested in 89bio in 2026 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
0.06% less ownership
Funds ownership: 0.06% → 0% (-0.06%)
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $1.11M → $0 (-$1.11M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
|
-$1.11M |
| 2 |
IA
IFP Advisors
Tampa,
Florida
|
-$252 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
| – | -$1.11M | -90,000 | Closed |
|
|
IA
2
IFP Advisors
Tampa,
Florida
| – | -$252 | -17 | Closed |
|
ETNB Hedge Fund Activity: Q1 2026 in Review
0 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in 89bio (ETNB) for Q1 2026, worth a combined $0 — down 100% from $1.11M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ETNB and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was DekaBank Deutsche Girozentrale, exiting entirely with an estimated $1.11M sold.
- 0 institutional investors held 89bio (ETNB) as of Q1 2026, down from 2 in Q4 2025.
- Funds reported $0 of 89bio stock for Q1 2026, down 100% quarter-over-quarter.
- 0 funds opened new 89bio positions in Q1 2026 and 2 closed out, a net change of -2 holders.
- The largest 89bio seller in Q1 2026 was DekaBank Deutsche Girozentrale, an estimated $1.11M sold.
Based on aggregated 13F filings for Q1 2026.